|

FOLFOX Protocol Clinical Trials

2 actively recruiting trials

Also known as: FOLFOX+/- bevacizumab

Pipeline

Phase 3: 2

Top Sponsors

  • Fudan University1
  • Centre Leon Berard1

Indications

  • Cancer2
  • GLUT31
  • MSI-H1
  • Vitamin C1
  • Advanced Cancer1

Other2 trials

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
Phase 3
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.